Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Design Therapeutics Inc is a preclinical-stage biopharmaceutical company. It is a pioneering novel small-molecule therapeutic candidate, called gene-targeted chimera, that are designed to be disease-modifying and target the underlying cause of inherited nucleotide repeat expansion diseases. Design Therapeutics Inc is a preclinical-stage biopharmaceutical company. It is a pioneering novel small-molecule therapeutic candidate, called gene-targeted chimera, that are designed to be disease-modifying and target the underlying cause of inherited nucleotide repeat expansion diseases.
| Período † | Variación(Ptos) | Variación % | Apertura | Precio Máximo | Precio Mínimo | Avg. Vol. diario | Precio Promedio Ponderado | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.18 | -3.72670807453 | 4.83 | 5.12 | 4.58 | 94812 | 4.77553983 | CS |
| 4 | -0.41 | -8.10276679842 | 5.06 | 5.57 | 4.04 | 184081 | 4.85222103 | CS |
| 12 | -1.8 | -27.9069767442 | 6.45 | 6.81 | 3.58 | 170992 | 4.87326999 | CS |
| 26 | -1.37 | -22.7574750831 | 6.02 | 7.77 | 3.58 | 170023 | 5.41330615 | CS |
| 52 | 1.7 | 57.6271186441 | 2.95 | 7.77 | 2.9109 | 224577 | 4.80394837 | CS |
| 156 | -15.04 | -76.3839512443 | 19.69 | 26.3 | 1.94 | 347132 | 6.59654812 | CS |
| 260 | -23.35 | -83.3928571429 | 28 | 50 | 1.94 | 299288 | 8.30519117 | CS |
Parece que no se ha autenticado. Haga click al botón de abajo para iniciar la sesión y ver los símbolos recientemente consultados.
Soporte: (55) 4170 8128 | soporte@advfn.mx
Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones
Hot Features
Premium
